Osteoporosis, 2 Vols
- 74 %

Osteoporosis, 2 Vols

Ed. by Robert Marcus, David Feldman and Jennifer Kelsey et al. . 3rd ed. . 2007 . Various pag. w. figs., col. plates. . 28,5 cm .
 Gebunden
Sofort lieferbar | Lieferzeit: Sofort lieferbar I

3rd edition 2008 ungelesen sehr guter Zustand Rechnung mit MwSt unused unread very good condition Bestellungen bis 15 Uhr werden am gleichen Werktag verschickt Now in its third edition Osteoporosis is the most comprehensive authoritative reference on this disease Written by renowned experts in the field this two-volume reference is a must-have for academic and medical libraries physicians researchers and any company involved in osteoporosis research and development Worldwide 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 percent continuing to make osteoporosis a hot topic in medicine This newest edition covers everything from basic anatomy and physiology to diagnosis management and treatment in a field where direct care costs for osteoporitic fractures in the U S reach up to 18 billion each year

Unser bisheriger Preis:ORGPRICE: 345,00 €

Jetzt 89,95 €*

Alle Preise inkl. MwSt. | Versandkostenfrei
ISBN-13:
9780123705440
Einband:
Gebunden
Seiten:
0
Autor:
Robert et al Marcus
Gewicht:
6000 g
SKU:
INF1000342050
Sprache:
Englisch
Beschreibung:

Now in its third edition, Osteoporosis , is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. Worldwide, 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 percent continuing to make osteoporosis a hot topic in medicine. This newest edition covers everything from basic anatomy and physiology to diagnosis, management and treatment in a field where direct care costs for osteoporitic fractures in the U.S. reach up to $18 billion each year.
NEW TO THIS EDITION:
Recognizes the critical importance of the Wnt signaling pathway for bone health
Incorporates new chapters on osteocytes, phosphatonins, mouse genetics, and CNS and bone
Examines essential updates on estrogen prevention and treatment and the recent results from the WHI
Discusses the controversial topics of screening and clinical trial design for drug registration
Includes essential updates on therapeutic uses of calcium, vitamin D, SERMS, bisphosphonates, and parathyroid hormone
Offers critical reviews of reproductive and hormonal risk factors, ethnicity, nutrition, therapeutics, management, and economics comprising a tremendous wealth of knowledge in a single source not found elsewhere